» Articles » PMID: 21655945

SWI/SNF Chromatin Remodeling Complex: a New Cofactor in Reprogramming

Overview
Publisher Springer
Specialty Cell Biology
Date 2011 Jun 10
PMID 21655945
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Induced pluripotent stem (iPS) cells can be derived from somatic cells. Four key factors are required in this process including Oct4, Sox2, Klf4 and c-Myc. Ectopic expression of these four factors in somatic cells leads to reprogramming. Recent studies show that the SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeling complex plays critical roles in reprogramming of somatic cells and maintaining the pluripotency of stem cells. The possible mechanism is that SWI/SNF enhances the binding activity of reprogramming factors to pluripotent gene promoters and thus increases the reprogramming efficiency. Here, we review these recent advances and discuss how SWI/SNF plays a role in reprogramming. Understanding this mechanism will be helpful to find out the detail of reprogramming, which may provide a new therapy in medical science by generating patient-specific pluripotent stem cells.

Citing Articles

Replication stress in mammalian embryo development, differentiation, and reprogramming.

Wang N, Xu S, Egli D Trends Cell Biol. 2023; 33(10):872-886.

PMID: 37202286 PMC: 11214770. DOI: 10.1016/j.tcb.2023.03.015.


CLOCK and TIMELESS regulate rhythmic occupancy of the BRAHMA chromatin-remodeling protein at clock gene promoters.

Tabuloc C, Cai Y, Kwok R, Chan E, Hidalgo S, Chiu J PLoS Genet. 2023; 19(2):e1010649.

PMID: 36809369 PMC: 9983840. DOI: 10.1371/journal.pgen.1010649.


Potential Role of SWI/SNF Complex Subunit Actin-Like Protein 6A in Cervical Cancer.

Wang Q, Cao Z, Wei Y, Zhang J, Cheng Z Front Oncol. 2021; 11:724832.

PMID: 34395295 PMC: 8358818. DOI: 10.3389/fonc.2021.724832.


Embryonic stem cell-specific microRNAs contribute to pluripotency by inhibiting regulators of multiple differentiation pathways.

Gruber A, Grandy W, Balwierz P, Dimitrova Y, Pachkov M, Ciaudo C Nucleic Acids Res. 2014; 42(14):9313-26.

PMID: 25030899 PMC: 4132708. DOI: 10.1093/nar/gku544.


Epigenetics of pluripotent cells.

Medvedev S, Pokushalov E, Zakian S Acta Naturae. 2013; 4(4):28-46.

PMID: 23346378 PMC: 3548172.

References
1.
Sridharan R, Tchieu J, Mason M, Yachechko R, Kuoy E, Horvath S . Role of the murine reprogramming factors in the induction of pluripotency. Cell. 2009; 136(2):364-77. PMC: 3273494. DOI: 10.1016/j.cell.2009.01.001. View

2.
Kim J, Auerbach J, Rodriguez-Gomez J, Velasco I, Gavin D, Lumelsky N . Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature. 2002; 418(6893):50-6. DOI: 10.1038/nature00900. View

3.
Singh A, Dalton S . The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell. 2009; 5(2):141-9. PMC: 2909475. DOI: 10.1016/j.stem.2009.07.003. View

4.
Ichida J, Blanchard J, Lam K, Son E, Chung J, Egli D . A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell. 2009; 5(5):491-503. PMC: 3335195. DOI: 10.1016/j.stem.2009.09.012. View

5.
Markoulaki S, Hanna J, Beard C, Carey B, Cheng A, Lengner C . Transgenic mice with defined combinations of drug-inducible reprogramming factors. Nat Biotechnol. 2009; 27(2):169-71. PMC: 2654270. DOI: 10.1038/nbt.1520. View